Ran Shibukawa
Overview
Explore the profile of Ran Shibukawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suzuki H, Egawa N, Imamura K, Kondo T, Enami T, Tsukita K, et al.
Mol Brain
. 2024 Mar;
17(1):14.
PMID: 38444039
Synucleinopathies refer to a group of disorders characterized by SNCA/α-synuclein (α-Syn)-containing cytoplasmic inclusions and neuronal cell loss in the nervous system including the cortex, a common feature being cognitive impairment....
2.
Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, Yada Y, et al.
iScience
. 2022 Mar;
25(4):103987.
PMID: 35330684
Retinal dystrophies (RDs) lead to irreversible vision impairment with no radical treatment. Although photoreceptor cells (PRCs) differentiated from human induced pluripotent stem cells (iPSCs) are essential for the study of...
3.
Yada Y, Suga M, Shibukawa R, Sagara Y, Okanishi Y, Enami T, et al.
Stem Cell Res
. 2021 Aug;
55:102504.
PMID: 34419750
Schizophrenia (SCZ) is one of the major psychiatric disorders. The genetic factor is certainly influential in the onset of the disease but is not decisive. There is no identified molecular/cellular...
4.
Imamura K, Sakurai Y, Enami T, Shibukawa R, Nishi Y, Ohta A, et al.
FEBS Open Bio
. 2021 Apr;
11(5):1452-1464.
PMID: 33822489
Human pathogenic RNA viruses are threats to public health because they are prone to escaping the human immune system through mutations of genomic RNA, thereby causing local outbreaks and global...
5.
Yada Y, Kondo T, Suga M, Tsukita K, Enami T, Shibukawa R, et al.
Stem Cell Res
. 2021 Mar;
53:102274.
PMID: 33714066
Idiopathic basal ganglia calcification (IBGC) is a rare neurodegenerative disease, characterized by abnormal calcium deposits in basal ganglia of the brain. The affected individuals exhibit movement disorders, and progressive deterioration...
6.
Katagami Y, Kondo T, Suga M, Yada Y, Imamura K, Shibukawa R, et al.
Stem Cell Res
. 2020 Dec;
49:102095.
PMID: 33291009
Glycogen storage disease type 1a (GSD1a) is an autosomal recessive disorder caused by mutations of the glucose-6-phosphatase (G6PC) gene. Mutations of the G6PC gene lead to excessive accumulation of glycogen...
7.
Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, et al.
Stem Cell Res
. 2020 May;
45:101787.
PMID: 32416577
Age-related macular degeneration (AMD) is a late-onset progressive blinding disease. We established human induced pluripotent stem cells (iPSCs) from an AMD patient. The generated iPSC line showed pluripotency markers and...
8.
Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, et al.
Stem Cell Res
. 2020 May;
45:101782.
PMID: 32416576
Best Disease is an inherited retinal dystrophy that results in progressive and irreversible central vision loss caused by mutations of BESTROPHIN1 (BEST1). We established human induced pluripotent stem cells (iPSCs)...
9.
Suzuki H, Egawa N, Kondo T, Imamura K, Enami T, Tsukita K, et al.
Stem Cell Res
. 2020 May;
45:101828.
PMID: 32413791
Parkinson's disease (PD) is a devastating movement disorder with an unknown etiology. Multiplications of the SNCA gene cause the autosomal dominant form of familial PD as well as missense mutations...
10.
Suga M, Kondo T, Imamura K, Shibukawa R, Okanishi Y, Sagara Y, et al.
Stem Cell Res
. 2019 Mar;
36:101406.
PMID: 30849633
Mucopolysaccharidosis type I (MPS I) is a rare inherited metabolic disorder caused by defects in alpha-L-iduronidase (IDUA), a lysosomal protein encoded by IDUA gene. MPS I is a progressive multisystemic...